• About
  • Keywords

Toxoplasma gondii & Human Phenotype

Compendium of Known Effects and Ongoing Research

psychiatry

Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses

May 11, 2017
Bortolato, B., Kohler, C.A., Evangelou, E., Leon-Caballero, J., Solmi, M., Stubbs, B., Belbasis, L., Pacchiarotti, I., Kessing, L.V., Berk, M., Vieta, E., Carvalho, A.F.
Bipolar Disorder 2017; 19: 84-96
Click for abstract
ObjectivesThe pathophysiology of bipolar disorder is likely to involve both genetic and environmental risk factors. In our study, we aimed to perform a systematic search of environmental risk factors for BD. In addition, we assessed possible hints of bias in this literature, and identified risk factors supported by high epidemiological credibility. MethodsWe searched the Pubmed/MEDLINE, EMBASE and PsycInfo databases up to 7 October 2016 to identify systematic reviews and meta-analyses of observational studies that assessed associations between putative environmental risk factors and BD. For each meta-analysis, we estimated its summary effect size by means of both random- and fixed-effects models, 95% confidence intervals (CIs), the 95% prediction interval, and heterogeneity. Evidence of small-study effects and excess of significance bias was also assessed. ResultsSixteen publications met the inclusion criteria (seven meta-analyses and nine qualitative systematic reviews). Fifty-one unique environmental risk factors for BD were evaluated. Six meta-analyses investigated associations with a risk factor for BD. Only irritable bowel syndrome (IBS) emerged as a risk factor for BD supported by convincing evidence (k=6; odds ratio [OR]=2.48; 95% CI=2.35-2.61; P<.001), and childhood adversity was supported by highly suggestive evidence. Asthma and obesity were risk factors for BD supported by suggestive evidence, and seropositivity to Toxoplasma gondii and a history of head injury were supported by weak evidence. ConclusionsNotwithstanding that several environmental risk factors for BD were identified, few meta-analyses of observational studies were available. Therefore, further well-designed and adequately powered studies are necessary to map the environmental risk factors for BD.

Tagged: aetiology, bipolar disorder, depression, mania, meta-analysis, mood disorder, psychiatry, Risk factor, systematic review

Mental healthReviews

Cerebral complement C1q activation in chronic Toxoplasma infection

May 24, 2016
Xiao, J.C., Li, Y., Gressitt, K.L., He, H., Kannan, G., Schultz, T.L., Svezhova, N., Carruthers, V.B., Pletnikov, M.V., Yolken, R.H., Severance, E.G.
Brain Behav. Immun. 2016; 58: 52-56
Click for abstract
Exposure to the neurotropic parasite, Toxoplasma gondii, causes significant brain and behavioral anomalies in humans and other mammals. Understanding the cellular mechanisms of T. gondii-generated brain pathologies would aid the advancement of novel strategies to reduce disease. Complement factor C1 q is part of a classic immune pathway that functions peripherally to tag and remove infectious agents and cellular debris from circulation. In the developing and adult brain, C1 q modifies neuronal architecture through synapse marking and pruning. T. gondii exposure and complement activation have both been implicated in the development of complex brain disorders such as schizophrenia. Thus, it seems logical that mechanistically, the physiological pathways associated with these two factors are connected. We employed a rodent model of chronic infection to investigate the extent to which cyst presence in the brain triggers activation of cerebral C1 q. Compared to uninfected mice, cortical C1 q was highly expressed at both the RNA and protein levels in infected animals bearing a high cyst burden. In these mice, C1 q protein localized to cytoplasm, adjacent to GFAP-labeled astrocytes, near degenerating cysts, and in punctate patterns along processes. In summary, our results demonstrated an upregulation of cerebral C1q in response to latent T. gondii infection. Our data preliminarily suggest that this complement activity may aid in the clearance of this parasite from the CNS and in so doing, have consequences for the connectivity of neighboring cells and synapses.

Tagged: glia, MAG1 antibodies, neurons, prefrontal cortex, psychiatry, toxoplasmosis

Mental health

Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling

January 4, 2016
Severance, E. G., Yolken, R. H., Eaton, W. W.
Schizophrenia Research, 2016, 176 :23-35
Click for abstract
Autoimmunity, gastrointestinal (GI) disorders and schizophrenia have been associated with one another for a long time. This paper reviews these connections and provides a context by which multiple risk factors for schizophrenia may be related. Epidemiological studies strongly link schizophrenia with autoimmune disorders including enteropathic celiac disease. Exposure to wheat gluten and bovine milk casein also contribute to non-celiac food sensitivities in susceptible individuals. Co-morbid GI inflammation accompanies humoral immunity to food antigens, occurs early during the course of schizophrenia and appears to be independent from antipsychotic-generated motility effects. This inflammation impacts endothelial barrier permeability and can precipitate translocation of gut bacteria into systemic circulation. Infection by the neurotropic gut pathogen, Toxoplasma gondii, will elicit an inflammatory GI environment. Such processes trigger innate immunity, including activation of complement C1q, which also functions at synapses in the brain. The emerging field of microbiome research lies at the center of these interactions with evidence that the abundance and diversity of resident gut microbiota contribute to digestion, inflammation, gut permeability and behavior. Dietary modifications of core bacterial compositions may explain inefficient gluten digestion and how immigrant status in certain situations is a risk factor for schizophrenia. Gut microbiome research in schizophrenia is in its infancy, but data in related fields suggest disease-associated altered phylogenetic compositions. In summary, this review surveys associative and experimental data linking autoimmunity, GI activity and schizophrenia, and proposes that understanding of disrupted biological pathways outside of the brain can lend valuable information regarding pathogeneses of complex, polygenic brain disorders. (C) 2014 Elsevier B.V. All rights reserved.

Tagged: autism spectrum disorders, autoimmunity, central-nervous-system, danish national registers, dtnbp1 dysbindin gene, gluten-free diet, human endogenous retrovirus, immune system, innate immune-response, intestinal, irritable-bowel-syndrome, microbiota, psychiatry, psychosis, recent-onset psychosis, toll-like receptor-4

Physical health

Difference of neuro- and immunomodulatory steroids and selected hormone and lipid concentrations between Toxoplasma-free and Toxoplasma-infected schizophrenia patients

September 27, 2014
Flegr, J., Hampl, R., Bicíková, M., Ripova, D., Mohr, P.
Neuroendocrinology Letters 2014; 35: 20-27
Click for abstract
OBJECTIVES : Toxoplasma gondii , the protozoan parasite infecting about 30% population worldwide, is suspected to be the etiological agent of certain form of schizophrenia disease. To x o p l a s m a is known to change levels of certain neu- rotransmitters, cytokines and several hormones in both infected animals and humans. A common feature of toxoplasmosis and schizophrenia is a disorder of immune system. METHODS: Here we studied the levels of five neuro- and immunomodulatory steroids, selected hormones and lipids in sera of 173 schizophrenia patients. RESULTS: To x o p l a s m a infected schizophrenia patients expressed only insignifi- cantly lower concentration of neuro- and immunomodulatory DHEA metabo- lites. Infected women had higher concentration of glucose while infected men had higher concentration of cholesterol and LDL cholesterol. No significant effect of human cytomegalovirus infection on the concentration of the above parameters was observed. The difference in the concentration of DHEA metabolites faded with the decrease of the concentration of anti- To x o p l a s m a IgG antibodies (i.e. with the duration of To x o p l a s m a infection) while the difference in the concentra- tion of cholesterol and LDL-cholesterol increased with the decrease of the con- centration of anti- To x o p l a s m a IgG antibodies. The prevalence of toxoplasmosis in male (53.2%) but not female (29.8%) schizophrenia patients was unusually high in comparison with prevalence of toxoplasmosis in a general population. CONCLUSION: Our results provided an explanation for seemingly decreasing prevalence of toxoplasmosis in schizophrenia patients observed in current studies (increased concerns about the rights of patients result- ing in absence of non-cooperative To x o p l a s m a -positive patients in the study population) and suggest possible explanation for reported positive correlation between prevalence of toxoplasmosis and incidence of cardio- vascular diseases (accelerated atherosclerotic develop- ment due to increased level of cholesterol and LDL in To x o p l a s m a infected humans).

Tagged: cardiovascular diseases, cholesterol, CMV, cortisol, cytomegalovirus, dehydroepaiandrosterone, heart disease, hypertensive heart disease, LD L, Low-density lipoprotein, manipulation hypothesis, metabolites, parasites, psychiatry, Schizophrenia, toxoplasmosis

Mental healthPhysical health

Immunity, inflammation, and bipolar disorder: Diagnostic and therapeutic implications

October 11, 2013
Hamdani, N., Doukhan, R., Kurtlucan, O., Tamouza, R., Leboyer, M.
Current Psychiatry Reports 2013; 15
Click for abstract
Bipolar disorder is now known to be associated not only with highly prevalent co-occurring psychiatric and substance use disorders but also with medical comorbidities, such as cardiovascular diseases, diabetes mellitus, obesity and thyroid dysfunction. Inflammatory disturbances repeatedly observed in bipolar disorder, can explain some of the comorbidity between bipolar disorder and medical disorder. This revised perspective of bipolar disorders should promote the development of therapeutic tools. Immuno-inflammatory dysfunction may well represent a significant component of the underlying pathophysiology of the disorder. We therefore propose to review the immuno-inflammatory hypothesis in bipolar disorder considering the co-occurence with autoimmune diseases, immunological and inflammatory markers, as well as immuno-genetic markers which could lead to personalized treatments.

Tagged: auto-antibody, autoimmune diseases, bipolar disorder, borna-disease virus, c-reactive protein, cardiovascular risk-factors, cell-mediated-immunity, crp, cytokines, depressive patients, endogenous retroviruses comorbid substance use disorder, immuno-genetic, lithium treatment, medical comorbidity, metabolic syndrome, mood disorders, psychiatry, Toxoplasma gondii

Mental health

Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: The TRAILS study

October 16, 2011
Wang, H., Yolken, R. H., Hoekstra, P. J., Burger, H., Klein, H. C.
Schizophrenia Research 2011; 129: 47-51
Click for abstract
nfections have been suggested to play a role in the etiology of schizophrenia, but the evidence for this has been inconsistent. Schizophrenia patients have an increased risk of infections as a result of hospitalizations or life style factors. Therefore a study on early subclinical manifestations of psychosis in relation to virus infections is warranted. We examined whether serum antibodies against human Herpes viruses and Toxoplasma gondii were associated with subclinical symptoms of psychosis in adolescents. Data were collected as part of the TRacking Adolescents' Individual Lives Survey (TRAILS) cohort, a large prospective cohort of Dutch adolescents. A total of 1176 participants with an available Community Assessment of Psychic Experiences (CAPE) and an available blood sample were included in this analysis. Solid-enzyme immunoassay methods were used to measure the presence of immunoglobulin G (IgG) antibodies in serum to the Herpes virus family and to T. gondii. There was no significant association between serologic evidence of infection with human Herpes viruses or T. gondii and the risk of subclinical positive experience of psychosis. Subjects with a positive serological reaction to Epstein-Barr Virus (EBV) had higher scores on the positive dimension of psychosis measured by CAPE (b = 0.03, P = 0.02). This significant association was observed in males, but not in females. The current study suggests that there is no significant association between serological evidence of infection to human Herpes viruses and positive subclinical experience of psychosis, whereas there was an association between EBV infection and subclinical psychotic symptoms in boys.

Tagged: adolescents, community sample, Epidemiology, epstein-barr-virus, general-population, herpes viruses, individuals, multiple sclerosis, nia, onset schizophrenia, psychiatry, risk, Toxoplasma gondii, toxoplasma-gondii episode schizophrea

Mental health

Topics

  • Behavior 105
  • Cognitive functions 64
  • Mental health 439
  • Morphology 6
  • Motor functions 10
  • Personality 36
  • Physical health 134
  • Reproduction 36
  • Reviews 40
  • Sensory functions 3
  • Uncategorized 2

Archives

Recent articles

  • Mortality Patterns of Toxoplasmosis and Its Comorbidities in Tanzania: A 10-Year Retrospective Hospital-Based Survey February 6, 2020
  • The role of latent toxoplasmosis in the aetiopathogenesis of schizophrenia–the risk factor or an indication of a contact with cat? February 6, 2020
  • The Association between Toxoplasma gondii Infection and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis February 6, 2020

Recent Comments

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Copyright © 2023 Toxoplasma gondii & Human Phenotype.

    ToxoBehavior WordPress Theme by Jelena Braum